Hormonal therapy of pancreatic carcinoma - Rationale and perspectives

Daniele Perilli, Carlo Mansi, Vincenzo Savarino, Guido Celle

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Exocrine pancreas carcinoma is still diagnosed at a relatively late stage, so that only a few cases can be cured by surgery. Therefore, it is desirable that an effective medical therapy be found first to stall the development of the disease and second to improve the life conditions of patients. On the basis of recent discoveries, a new therapeutic approach seems to derive from hormone manipulation. The growth of pancreatic carcinoma appears to be stimulated by various factors, such as Epidermal Growth Factor (EGF) and Insulin-like Growth Factor I (IGF-I), and by various hormones, such as androgens and cholecystokinin. Several studies performed on cell lines and on animal models of pancreatic carcinoma demonstrated an antitumoral effect of certain antihormones and of somatostatin. Taking such studies as a premise, the first clinical studies were finally started in patients suffering from nonoperable pancreatic cancer. Results are still partial and contradictory, but such research is certainly worthy of further study along the lines already taken.

Original languageEnglish
Pages (from-to)159-168
Number of pages10
JournalInternational Journal of Pancreatology
Volume13
Issue number3
DOIs
Publication statusPublished - Jun 1993

Fingerprint

Hormones
Exocrine Pancreas
Cholecystokinin
Somatostatin
Pancreatic Neoplasms
Insulin-Like Growth Factor I
Epidermal Growth Factor
Androgens
Animal Models
Carcinoma
Cell Line
Therapeutics
Growth
Research
Pancreatic Carcinoma
Clinical Studies

Keywords

  • Gastrointestinal hormones
  • growth factors
  • sex hormones
  • somatostatin

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Endocrinology

Cite this

Hormonal therapy of pancreatic carcinoma - Rationale and perspectives. / Perilli, Daniele; Mansi, Carlo; Savarino, Vincenzo; Celle, Guido.

In: International Journal of Pancreatology, Vol. 13, No. 3, 06.1993, p. 159-168.

Research output: Contribution to journalArticle

Perilli, Daniele ; Mansi, Carlo ; Savarino, Vincenzo ; Celle, Guido. / Hormonal therapy of pancreatic carcinoma - Rationale and perspectives. In: International Journal of Pancreatology. 1993 ; Vol. 13, No. 3. pp. 159-168.
@article{08dff457a7ba4d72b05342d002f87e50,
title = "Hormonal therapy of pancreatic carcinoma - Rationale and perspectives",
abstract = "Exocrine pancreas carcinoma is still diagnosed at a relatively late stage, so that only a few cases can be cured by surgery. Therefore, it is desirable that an effective medical therapy be found first to stall the development of the disease and second to improve the life conditions of patients. On the basis of recent discoveries, a new therapeutic approach seems to derive from hormone manipulation. The growth of pancreatic carcinoma appears to be stimulated by various factors, such as Epidermal Growth Factor (EGF) and Insulin-like Growth Factor I (IGF-I), and by various hormones, such as androgens and cholecystokinin. Several studies performed on cell lines and on animal models of pancreatic carcinoma demonstrated an antitumoral effect of certain antihormones and of somatostatin. Taking such studies as a premise, the first clinical studies were finally started in patients suffering from nonoperable pancreatic cancer. Results are still partial and contradictory, but such research is certainly worthy of further study along the lines already taken.",
keywords = "Gastrointestinal hormones, growth factors, sex hormones, somatostatin",
author = "Daniele Perilli and Carlo Mansi and Vincenzo Savarino and Guido Celle",
year = "1993",
month = "6",
doi = "10.1007/BF02924436",
language = "English",
volume = "13",
pages = "159--168",
journal = "International Journal of Gastrointestinal Cancer",
issn = "1537-3649",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Hormonal therapy of pancreatic carcinoma - Rationale and perspectives

AU - Perilli, Daniele

AU - Mansi, Carlo

AU - Savarino, Vincenzo

AU - Celle, Guido

PY - 1993/6

Y1 - 1993/6

N2 - Exocrine pancreas carcinoma is still diagnosed at a relatively late stage, so that only a few cases can be cured by surgery. Therefore, it is desirable that an effective medical therapy be found first to stall the development of the disease and second to improve the life conditions of patients. On the basis of recent discoveries, a new therapeutic approach seems to derive from hormone manipulation. The growth of pancreatic carcinoma appears to be stimulated by various factors, such as Epidermal Growth Factor (EGF) and Insulin-like Growth Factor I (IGF-I), and by various hormones, such as androgens and cholecystokinin. Several studies performed on cell lines and on animal models of pancreatic carcinoma demonstrated an antitumoral effect of certain antihormones and of somatostatin. Taking such studies as a premise, the first clinical studies were finally started in patients suffering from nonoperable pancreatic cancer. Results are still partial and contradictory, but such research is certainly worthy of further study along the lines already taken.

AB - Exocrine pancreas carcinoma is still diagnosed at a relatively late stage, so that only a few cases can be cured by surgery. Therefore, it is desirable that an effective medical therapy be found first to stall the development of the disease and second to improve the life conditions of patients. On the basis of recent discoveries, a new therapeutic approach seems to derive from hormone manipulation. The growth of pancreatic carcinoma appears to be stimulated by various factors, such as Epidermal Growth Factor (EGF) and Insulin-like Growth Factor I (IGF-I), and by various hormones, such as androgens and cholecystokinin. Several studies performed on cell lines and on animal models of pancreatic carcinoma demonstrated an antitumoral effect of certain antihormones and of somatostatin. Taking such studies as a premise, the first clinical studies were finally started in patients suffering from nonoperable pancreatic cancer. Results are still partial and contradictory, but such research is certainly worthy of further study along the lines already taken.

KW - Gastrointestinal hormones

KW - growth factors

KW - sex hormones

KW - somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0027175509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027175509&partnerID=8YFLogxK

U2 - 10.1007/BF02924436

DO - 10.1007/BF02924436

M3 - Article

C2 - 8103783

AN - SCOPUS:0027175509

VL - 13

SP - 159

EP - 168

JO - International Journal of Gastrointestinal Cancer

JF - International Journal of Gastrointestinal Cancer

SN - 1537-3649

IS - 3

ER -